Cargando…
Public Knowledge of Benefits of Breast and Prostate Cancer Screening in Europe
Making informed decisions about breast and prostate cancer screening requires knowledge of its benefits. However, country-specific information on public knowledge of the benefits of screening is lacking. Face-to-face computer-assisted personal interviews were conducted with 10 228 persons selected b...
Autores principales: | Gigerenzer, Gerd, Mata, Jutta, Frank, Ronald |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2736294/ https://www.ncbi.nlm.nih.gov/pubmed/19671770 http://dx.doi.org/10.1093/jnci/djp237 |
Ejemplares similares
-
Prostate-Specific Antigen Screening and Recent Increases in Advanced Prostate Cancer
por: Nyame, Yaw A, et al.
Publicado: (2020) -
Prostate-Specific Antigen Screening in the United States vs in the European Randomized Study of Screening for Prostate Cancer–Rotterdam
por: Wever, Elisabeth M., et al.
Publicado: (2010) -
Predicted Chemotherapy Benefit for Breast Cancer Patients With Germline Pathogenic Variants in Cancer Susceptibility Genes
por: Kurian, Allison W, et al.
Publicado: (2020) -
Using variation between countries to estimate demand for Cochrane reviews when access is free: a cost–benefit analysis
por: Jacobs, Perke, et al.
Publicado: (2021) -
US gynecologists’ estimates and beliefs regarding ovarian cancer screening’s effectiveness 5 years after release of the PLCO evidence
por: Wegwarth, Odette, et al.
Publicado: (2018)